<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01871922</url>
  </required_header>
  <id_info>
    <org_study_id>Retro-002</org_study_id>
    <nct_id>NCT01871922</nct_id>
  </id_info>
  <brief_title>Atropine-effect During Propofol/Remifentanil Induction</brief_title>
  <official_title>Evaluation of the Effects of the Addition of Atropine During Propofol/Remifentanil Induction of Anesthesia on Hemodynamics, Microvascular Blood Flow and Tissue Oxygenenation in Patients Undergoing Ophthalmic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Remifentanil is a widely used potent intravenous opioid with the advantage of having a short
      time of action. Compared to other opiates however remifentanil generates more intense
      hemodynamic side-effects. In ophthalmic surgery the specific anesthesiological challenges
      necessitate the administration of a combination of relatively high doses of analgesics on the
      one hand and a short time for postoperative recovery from anesthesia on the other. For these
      reasons, anesthetic management often consists of a combination of relatively high doses of
      propofol and remifentanil. A primary concern during this deep propofol/remifentanil
      anesthesia is preserving hemodynamic stability and adequate tissue oxygenation. Previous
      research of the investigators group has revealed that atropine has an exceptionally
      beneficial effect on hemodynamics as well as on tissue oxygenation. Therefore, the
      investigators hypothesize that administration of intravenous atropine during induction of
      propofol/remifentanil may have a positive effect on the hemodynamic profile and peripheral
      and cerebral tissue oxygenation during and after induction of anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>During anesthesia</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Peripheral tissue oxygen saturation</measure>
    <time_frame>During anesthesia</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral tissue oxygen saturation</measure>
    <time_frame>During anesthesia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>During anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>During anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic vascular resistance</measure>
    <time_frame>During anesthesia</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Anesthesia-induced Negative Hemodynamic Effects</condition>
  <arm_group>
    <arm_group_label>General anesthesia + placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Propofol/remifentanil anesthesia + saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General anesthesia + atropine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol/remifentanil anesthesia + atropine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Saline</description>
    <arm_group_label>General anesthesia + placebo</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atropine</intervention_name>
    <description>Atropine</description>
    <arm_group_label>General anesthesia + atropine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients requiring general anaesthesia;

          -  Patient's age â‰¥ 18 years and older;

          -  Patient and surgical procedure appropriate for treatment with either sufentanil or
             remifentanil.

        Exclusion Criteria:

          -  Patient's refusal;

          -  Pregnancy;

          -  Patient's age &lt; 18 years;

          -  Patients in which atropine is contra-indicated, such as severe aortic valve stenosis,
             hypertrophic cardiomyopathy or coronary artery disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain F Kalmar, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2013</study_first_submitted>
  <study_first_submitted_qc>June 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2013</study_first_posted>
  <last_update_submitted>January 30, 2014</last_update_submitted>
  <last_update_submitted_qc>January 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Groningen</investigator_affiliation>
    <investigator_full_name>A.F.Kalmar</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Atropine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

